1. Problem Diagnosis
The surface causes of healthcare crises vary, but the structural root is the same: healthcare has been commodified, and public health has been eroded by the logic of profit.
This manifests at three levels:
- Healthcare costs crush households: In the US, medical bills are a leading cause of bankruptcy. In other countries, out-of-pocket payments push families into poverty. Healthcare is treated as a market transaction, not a right.
- Pharmaceutical capital captures health value: Transnational pharmaceutical companies set monopoly prices for patented drugs, often funded by public research. Insurance capital extracts profits from risk pooling. The value of health flows to private capital, not to public health.
- Public health is marginalized: Prevention, sanitation, nutrition, and health education — the foundations of population health — are underfunded. Systems focus on treatment (which is profitable) rather than prevention (which is not).
The result: people pay more for healthcare, but live less healthy lives. Systems treat disease, not health.
2. Universal Logic (Non-Negotiable)
The following are the core requirements of the Governance Legitimacy Framework for domestic healthcare policy. These principles are globally universal; no country can bypass them.
1. Land value must be publicly captured to finance universal healthcare. A portion of land value increment must be earmarked for public health systems, ensuring that healthcare funding does not depend on employer contributions or out-of-pocket payments. This is the fiscal foundation of health equity.
2. Healthcare must be a public good, not a market commodity. Universal healthcare coverage must be legally guaranteed, funded publicly, and delivered based on need, not ability to pay.
3. Public health must be prioritized over treatment. Systems must invest in prevention, sanitation, nutrition, and health education — the foundational determinants of population health. Treatment is important, but it is downstream.
4. Pharmaceutical pricing must be publicly regulated. Patent monopolies must not allow transnational pharmaceutical companies to set prices that exclude patients. Public funding of research must come with public control of pricing.
5. Healthcare access must be decoupled from employment. Health coverage must be tied to citizenship or residence, not to employment status. Employer-tied healthcare traps workers in jobs and excludes the unemployed, gig workers, and retirees.
3. Local Rules (Locally Tailored)
The following are the concrete policy tools that countries can design according to their own conditions. These tools have no globally uniform standard; they must be locally tailored.
1. Healthcare financing models. Countries may choose different models based on their fiscal systems and social contracts:
- Single-payer national health service: Government-funded and delivered (e.g., UK NHS, Canada).
- Social health insurance: Mandatory insurance with public regulation, decoupled from employers (e.g., Germany, Japan, Taiwan).
- National health insurance: Single public insurer with private delivery (e.g., Taiwan, South Korea).
- Mixed system: Public and private insurance coexisting, with universal floor (e.g., Australia, Netherlands).
2. Pharmaceutical pricing and procurement. Countries may design different frameworks based on their market conditions:
- Reference pricing: Setting prices based on international comparison.
- Value-based pricing: Setting prices based on health outcomes, not on patent monopolies.
- Compulsory licensing: Allowing domestic production of patented drugs in public health emergencies.
- Pooled procurement: Joint purchasing by multiple countries to negotiate lower prices.
- Public research, public pricing: Requiring public control of pricing for drugs developed with public funding.
3. Public health infrastructure. Countries may design different systems based on their administrative conditions:
- Primary care networks: Community-based primary care as the foundation of the health system.
- Preventive care incentives: Public funding for vaccination, screening, and health education.
- Public health workforce: Training and deploying community health workers, especially in underserved areas.
- Environmental health: Integrating environmental protection with public health (air quality, water quality, sanitation).
4. Decoupling healthcare from employment. Countries may design different policies based on their administrative systems:
- Universal coverage: Health coverage based on residence, not employment.
- Portable benefits: Health coverage follows workers across jobs and locations.
- Gig worker coverage: Health coverage for platform workers and independent contractors.
- Unemployment bridge: Health coverage continues during unemployment.
5. Healthcare quality and equity measurement. Countries may design different measurement frameworks based on their statistical capacity:
- Access indicators: Measuring unmet healthcare needs, waiting times, and out-of-pocket costs.
- Outcome indicators: Measuring life expectancy, preventable mortality, and health disparities.
- Equity indicators: Measuring health outcomes by income, region, and social group.
- Financial protection: Measuring the share of households pushed into poverty by medical expenses.
4. The Necessity of Cross-Border Coordination
Why must domestic healthcare reform be combined with global coordination?
Because pharmaceutical capital is transnational. If one country negotiates lower drug prices, pharmaceutical companies can threaten to withhold supply or relocate. If one country invests in public health, its gains can be undermined by drug prices set globally.
Only global coordination can prevent pharmaceutical arbitrage. This requires:
- Uniform land value capture floor: To ensure all countries have the fiscal resources for universal healthcare.
- Beneficial ownership registry: To prevent pharmaceutical companies from hiding behind offshore structures.
- Pooled procurement: Joint purchasing by multiple countries to negotiate lower drug prices.
- Public research, public pricing: Global framework requiring public control of pricing for publicly funded research.
- Capital flow stabilization fund: To provide liquidity support for countries investing in public health against capital flight.
Precedents already exist: The Basel Accords for bank capital standards, FATF for anti-money laundering, BEPS for global minimum corporate tax. Cross-border coordination is not an ideal — it is a fact.
5. Conclusion
The core of domestic healthcare reform is the institutional design of universal public health financed by land value capture.
It must simultaneously satisfy two conditions:
- Consistent with universal logic: public capture of land value for healthcare; healthcare as a public good; priority on public health and prevention; regulated pharmaceutical pricing; decoupling from employment.
- Respectful of local differences: healthcare financing models; pharmaceutical pricing frameworks; public health infrastructure; decoupling policies; quality and equity measurement.
Only when the underlying logic is globally universal and the concrete rules are locally tailored can countries preserve their policy space while preventing capital flight.
Healthcare is not a market — it is the institutional foundation of human dignity. A society that treats health as a commodity is not a healthy society.
This essay follows the foundational principle: universal logic, local rules. For the full methodological framework, see Universal Logic, Local Rules →